Two Phase III , randomized , controlled studies with identical design in which subjects with moderate erythema of rosacea ( study A : n = 260 ; study B : n = 293 ) were randomized 1:1 to apply topical BT 0.5 % or vehicle gel once-daily for 4 weeks .